Hamsoa Dr Atoby
NDC Package 50964-080-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Hamsoa Dr Atoby is a . Marketed by Hamsoa Pharmaceutical Co., Ltd., this product is identified by NDC 50964-080 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
50964-080-01
Package Description
60 g in 1 CARTON
Product Code
50964-080
11-Digit Billing Format
50964008001

Clinical Specifications

Proprietary Name
Hamsoa Dr Atoby
Dosage Form
-

Regulatory & Marketing

Labeler Name
Hamsoa Pharmaceutical Co., Ltd.
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-01-2012
End Marketing Date
12-30-2014
Listing Expiration
12-30-2014
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50964-080-01 identifies a specific commercial package of 60 g in 1 carton of Hamsoa Dr Atoby, labeled by Hamsoa Pharmaceutical Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hamsoa Pharmaceutical Co., Ltd. on March 01, 2012. The current certification is valid through December 30, 2014.

How is this Hamsoa Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50964008001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50964-080-01
11-Digit CMS (5-4-2)
50964-0080-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.